Australia's most trusted
source of pharma news
Friday, 10 July 2026
Posted 9 July 2026 PM
Eli Lilly Australia and Diabetes Australia have joined forces, investing $680,000 in Menzies School of Health Research to expand digital health solutions for complex care in the Northern Territory.
The joint grant, which includes a $430,000 contribution from Lilly, will enable Menzies to expand its innovative work to address leading health complications for Territorians, including diabetes, cardiovascular and kidney disease.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.